PLoS Pathogens (Jan 2012)

LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs.

  • Rik Schrijvers,
  • Jan De Rijck,
  • Jonas Demeulemeester,
  • Noritaka Adachi,
  • Sofie Vets,
  • Keshet Ronen,
  • Frauke Christ,
  • Frederic D Bushman,
  • Zeger Debyser,
  • Rik Gijsbers

DOI
https://doi.org/10.1371/journal.ppat.1002558
Journal volume & issue
Vol. 8, no. 3
p. e1002558

Abstract

Read online

Lens epithelium-derived growth factor (LEDGF/p75) is a cellular cofactor of HIV-1 integrase (IN) that interacts with IN through its IN binding domain (IBD) and tethers the viral pre-integration complex to the host cell chromatin. Here we report the generation of a human somatic LEDGF/p75 knockout cell line that allows the study of spreading HIV-1 infection in the absence of LEDGF/p75. By homologous recombination the exons encoding the LEDGF/p75 IBD (exons 11 to 14) were knocked out. In the absence of LEDGF/p75 replication of laboratory HIV-1 strains was severely delayed while clinical HIV-1 isolates were replication-defective. The residual replication was predominantly mediated by the Hepatoma-derived growth factor related protein 2 (HRP-2), the only cellular protein besides LEDGF/p75 that contains an IBD. Importantly, the recently described IN-LEDGF/p75 inhibitors (LEDGINs) remained active even in the absence of LEDGF/p75 by blocking the interaction with the IBD of HRP-2. These results further support the potential of LEDGINs as allosteric integrase inhibitors.